Prof. Dr. Yuri (Jurijus) Gleba, CEO and majority shareholder of NOMAD Bioscience, has supported Ukrainian Army by donating 100 thousand Euro to reinforce the defense against Russian aggression
Prof. Dr. Yuri (Jurijus) Gleba, renown scientist and entrepreneur, CEO and major shareholder of Nomad Bioscience GmbH, a German biotechnology company, has donated 100 thousand Euro to the Armed Forces of Ukraine to support the defense against Russian aggression. Prof. Gleba also pledged his future support and expressed his gratitude to all researchers and businessmen worldwide who condemned the war of terrorist Russian state against Ukraine and are supporting Ukrainians in their patriotic fight.
Dr. A. Gyrych, CSO of NOMAD, Prof. Y. Gleba, and other Nomad colleagues are actively supporting Ukraine by donations, helping refugees, and providing help to their colleagues and other people in Ukraine.
Nomad Bioscience GmbH, headquartered in Munich, Germany, is a private biotechnology company developing plant-made biopharmaceuticals, food additives, biomaterials and agronomic traits that address critical unmet needs. NOMAD’s plant-based transient protein expression technologies are licensed to several companies for a broad range of products. NOMAD’s product pipeline consists of several selected protein candidates for human and animal health, food safety and taste modification including antimicrobial proteins (colicins, lysins and other bacteriocins), antiviral proteins such as griffithsin and other lectins, as well as taste modifying proteins including thaumatins.